The Blue Cross Blue Shield Association (BCBSA), partnering with the National Minority Quality Forum (NMQF), has released recommendations for improving and standardizing data collection methods around race, ethnicity, and language (REL) and sexual orien…
Hospital margins are still struggling, but they’re beginning to stabilize, according to Kaufman Hall’s National Hospital Flash Report for March.
Margins in February were down slightly from the previous month, representing the eighth straight month in w…
Providers and payers are speaking out against a Texas court decision yesterday that blocks preventative care coverage, including for HIV, cancer, and a range of reproductive health interventions, mandated in the Affordable Care Act.
The attorney general of Ohio is accusing pharmacy benefit managers of illegally driving up drug prices. What are the details? We’ll examine that and other issues in this week’s Top Stories, including Better Therapeutics’ recent layoffs, and clinicians …
New legislation introduced in the Senate by Bill Cassidy (R-LA) and Jeff Merkley (D-OR) seeks to curb overpayments to Medicare Advantage plans by imposing changes to MA risk adjustment.
Insurer Centene has appointed Tanya McNally to the role of senior vice president and chief people officer, the company announced this week.
As chief people officer, McNally will lead the Human Resources function and “drive strategies to optimize employ…
Ahead of a final rule that would limit the amount of time insurers have to approve prior authorization requests and would require an electronic, FHIR API standard, UnitedHealth Group on Wednesday said it would reduce the use of its prior authorization …
Is big data too big? Next month, Kristen Mclaughlin and Nitin Gupta will attempt an answer.
The Food and Drug Administration has approved the first nonprescription, “over-the-counter” naloxone nasal spray, Narcan.
Insurtech Oscar Health has named Mark Bertolini as its new chief executive officer, with Bertolini slated to officially take over the role on April 3.
